Jerry S. Lanchbury, Chief Scientific Officer at MYRIAD GENETICS INC (MYGN), sold 100,000 shares at $32.47 ($3.3M) on 2021-07-09, disclosed to the SEC on 2021-07-12.
Open-market sale of $3.3M MYGN by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $32.29 | 5,603 | $181K | 5.5% |
| 2 | $32.29 | 5,603 | $181K | 5.5% |
| 3 | $32.47 | 17,692 | $574K | 17.6% |
| 4 | $32.47 | 17,692 | $574K | 17.6% |
| 5 | $32.79 | 26,705 | $876K | 26.8% |
| 6 | $32.79 | 26,705 |
| $876K |
| 26.8% |
| Total | $32.62 avg | 100,000 | $3.3M | 100% |
| Filing → |
| MYGN | SELL | 2021-08-06 | $2.0M | — | Filing → |
| MYGN | SELL | 2021-08-05 | $4.5M | — | Filing → |
| MYGN | SELL | 2021-07-14 | $4.9M | — | Filing → |